Animal-Derived Pharmaceutical Proteins

Abstract Abstract Livestock animals have made a significant contribution to human health and well-being throughout humankind's history. A significant contribution of farm animals to human health are the longstanding use of bovine and porcine for production of insulin (for treatment of diabetes), gelatin (for pharmaceutical and other purposes), as well as horse and sheep antibody against natural venoms, toxins, drugs and microbial peptides. Gelatin being the biggest animal protein consumed in human health, follows with antibodies fragments. The chronic problem of animal-derived therapeutics, especially those of high molecular weight, is the immunogenicity induction in addition to their biosafety. However, the invertebrates and lower vertebrates donate the human being a several crucial emergency saving life small-peptides or their analogs such as RefludanR, PrialtR, ExendinR. Not only, but the farm animals are enormously using as models for novel surgical strategies, testing of biodegradable implants and sources of tissue replacements, such as skin and heart valves. Recently, they are being harnessing as bioreactor for production of biopharmaceutical related products through gene farming with efficiency far greater than any conventional microbial or cell-culture production systems. Only 16 transgenic cows would be covering the worldwide needs from human growth hormone. The transgenic, especially animal, technology would be solving a several biopharmaceutical products disadvantages, such as cost, biosafety, immunogenicity and the availability dimensions. Keywords: AnimalsAnti-serumDerived-pharmaceuticalsGelatinInsulinSmall peptidesTherapeutic proteinsTransgenic-animal ACKNOWLEDGMENT This work has been partially supported by MUCSAT, and grants No. 86 and RPC11.3/R6/81/1 from Egyptian Academy of Science and Technology, WHO/EMRO-COMSTECH for E.M.R. My deep and warm appreciation to my colleagues and family for unlimited support and encouragements. Manuscript 3310